These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21242851)

  • 21. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
    Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
    Singh M; Gautam N; Kaur M
    Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.
    Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA
    Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
    Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
    Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL; Ramasubramanian A; Mellen PL; Shields JA
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers.
    Shields CL; Paulose SA; Yaghy A; Dalvin LA; Constantinescu AB; Lally SE; Shields JA
    Cornea; 2021 Nov; 40(11):1387-1394. PubMed ID: 33273189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia.
    Lee GA; Hess L; Glasson WJ; Whitehead K
    Cornea; 2018 Jun; 37(6):796-798. PubMed ID: 29489517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular surface squamous neoplasia after corneal graft.
    Ramasubramanian A; Shields CL; Sinha N; Shields JA
    Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
    Ma IH; Hu FR; Wang IJ; Chen WL; Hsu YJ; Chu HS; Yuan CT; Hou YC
    J Formos Med Assoc; 2019 Apr; 118(4):776-782. PubMed ID: 30266199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study.
    Karp CL; Galor A; Lee Y; Yoo SH
    Ocul Immunol Inflamm; 2010 Aug; 18(4):254-60. PubMed ID: 20662655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular surface squamous neoplasia as the initial presenting sign of human immunodeficiency virus infection in 60 Asian Indian patients.
    Kaliki S; Kamal S; Fatima S
    Int Ophthalmol; 2017 Oct; 37(5):1221-1228. PubMed ID: 27826936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease.
    Zhang L; Mercado C; Galor A; Holland EJ; Wang G; Karp CL
    Ocul Immunol Inflamm; 2019; 27(2):288-293. PubMed ID: 29190165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodulo-Ulcerative Ocular Surface Squamous Neoplasia in 6 Patients: A Rare Presentation.
    Kaliki S; Freitag SK; Chodosh J
    Cornea; 2017 Mar; 36(3):322-326. PubMed ID: 27749454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
    Kanaya R; Kase S; Ishijima K; Ishida S
    In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.